Drugs for Rare Diseases
Drugs for Rare Diseases, Total:173 items.
The international standard classification for "Drugs for Rare Diseases" includes: Medical Sciences and health care facilities in general , Transport by water .
The Chinese standard classification for "Drugs for Rare Diseases" includes: Medical science , Diving and its physiological condition , Diagnostic standard for public nuisance diseases .
Jiangsu Provincial Standard of the People's Republic of China
- DB32/T 4688.9-2024 Technical Guidelines for AIDS Prevention and Treatment Part 9: Drug Maintenance Treatment
- DB32/T 4698-2024 Standardization of diagnostic and treatment paths for treating pre-diseases with traditional Chinese medicine
- DB32/T 4250-2021 Technical specifications for quality control of HIV antiretroviral treatment
- DB32/T 4688.9-2024 Technical Guidelines for AIDS Prevention and Treatment Part 9: Drug Maintenance Treatment
- DB32/T 4187-2021 Technical specification for quality control of AIDS antiretroviral treatment
Group Standards of the People's Republic of China
- T/SAME 003-2023 Standard for quality control of theraputic drug monitoring in neuropsychopharmacology
- T/CMAM W3-2022 Diagnosis and Treatment Guidelines for Common Diseases in Uyghur Medicine
- T/CHATA 031-2023 Chemotherapy for Drug-Resistant Tuberculosis in Children and Adolescents
- T/CAPC 012-2023 Standards for pharmaceutical care of retail pharmacies supplying diabetes, hypertension and dyslipidemia medications
- T/CACM 012-2017 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for sepsis
- T/CMAM K 13-2022 Diagnosis and Treatment Guidelines for Common Diseases of Kazakh Medicine Gynecology
- T/TIC 015-2023 Rheumatism treatment technical specifications
- T/CAPC 015-2024 Specification for pharmaceutical care of pharmacies retailing thyroid disease medications
- T/CHSA 013-2023 Guidelines of orthodontic treatment for patients with periodontitis
- T/CHAS 20-2-11-2022 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 2-11: Pharmacy practice——Therapeutic drug monitoring
- T/CACM 009-2017 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for acute upper respiratory tract infection in children
- T/CHATA 041-2024 Treatment guidelines for rifampicin-resistant tuberculosis
- T/CACM 1570.4-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials?—?Salviae Miltiorrhizae Radix et Rhizoma (Salvia miltiorrhiza Bunge)
- T/CACM 010-2017 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for pelvic inflammatory disease
- T/CACM 1104-2018 Technical Operation Standards for Preventive Treatment of Diseases in Traditional Chinese Medicine
- T/CACM 011-2016 Simple lower urinary tract infection
- T/CACM 1570.2-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials— Asia ginseng (Panax ginseng C. A. Meyer)
- T/LZSZZHY 010-2024 Technical specifications for prevention and treatment of common Tibetan pig diseases
- T/CHATA 021-2022 Drug treatment guidelines for different grades of liver injury caused by anti-tuberculosis drugs
- T/SAIA 006-2022 Technical specification for comprehensive control of common diseases of equine animals
- T/CAPC 014-2023 Standards for pharmaceutical care of retail pharmacies supplying psoriasis medications
- T/CACM 006-2017 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for community-acquired pneumonia
- T/SATCM 0005-2025 Expert consensus on acupuncture treatment for diabetic peripheral neuropathy
- T/GXAS 660-2023 Specification for traditional Chinese medicine external treatment of acquired immuno deficiency syndrome common diseases
- T/CVMA 64-2021 Guidelines for the Treatment of Chronic Kidney Disease in Dogs and Cats
- T/CADERM 3012-2019 Specifications for diagnosis and treatment of rabies
- T/CMAM T28-35-2019 Evaluating Criteria for Curative Effect of Common Diseases of Tujia Medicine
- T/CACM 1447-2023 Intervention guidelines for prevention of winter diseases in summer using acupoint application therapy
- T/CACM 1570.3-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials— Chuanxiong Rhizoma(Ligusticum chuanxiong Hort.)
- T/CACM 1570.1-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials — General principles
- T/CACM 1570.6-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials—Angelica sinensis Radix[Angelica sinensis (Oliv.) Diels]
- T/CHATA 033-2024 Guidelines for the Treatment and Management of Patients with Concurrent Tuberculosis and Diabetes Mellitus
- T/CMAM M1-M9-2018 Diagnosis and Treatment Guidelines for Common Diseases of Mongolian Medicine
- T/CACM 1570.5-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials?—?Rehmanniae Radix (Rehmannia glutinosa Libosch.)
- T/CMAM T20-27-2019 Diagnosis and Treatment Guidelines for Common Diseases of Tujia Medicine
- T/CACM 1105-2018 Traditional Chinese medicine medicine bath
- T/LZZLXH 50-2021 Technical specifications for prevention and control of common diseases in Tibetan pigs
- T/CACM 008-2018 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for acute pharyngitis
- T/CMAM K 14-2022 Diagnosis and Treatment Guidelines for Common Diseases of Kazakh Medicine Orthopedics
- T/CACM 1101-2018 Technical Operation Standards for Prevention and Treatment of Traditional Chinese Medicine
- T/TIC 012-2023 Pain treatment system
- T/CACM 007-2017 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for acute tonsillitis
- T/CLPA 003-2023 Pharmaceutical Service Guidelines for Endocrine Therapy of Breast Cancer (2023 Edition)
Guangxi Provincial Standard of the People's Republic of China
- DB45/T 2790-2023 Zhuang Medicine Bamboo Pot Treatment and Nursing Technical Operation Specifications
- DB45/T 2113-2020 Zhuang medicine acupoints combined with drug hot ironing therapy for Pangbayin technical specifications
- DB45/T 1087.3-2017 Technical regulations for diagnosis and treatment of common freshwater cultured fish diseases Part 3: Drug efficacy test for disease prevention and control
- DB45/T 2786-2023 Technical specifications of Zhuang medicine bamboo pot therapy for the treatment of knee osteoarthritis
General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China
- GB/T 17870-1999 Technical requirements of recompression therapy for decompression sickness
- GB/T 31720-2015 Insecticide resistance management for vector―General rules
Shanxi Provincial Standard of the People's Republic of China
- DB1410/T 129-2022 Technical specification for prevention and control of common garden plant diseases and insect pests
Professional Standard - Agriculture
- 49药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Drugs for Other Movement Disorders 2. Anti-Parkinson's Drug Trihexyphenidyl Hydrochloride
- 110药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 2. Cerebral Vasodilators Ginkgo Biloba Extract
- 103药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 2. Nimodipine, a Cerebral Vasodilator
- 94药典 三部-2015 Monograph Ⅱ Therapeutic antirabies serum
- 1038药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Tumor Adjuvant Mesna
- 703药典 化学药和生物制品卷-2010 Chapter 9 Endocrine System Drugs Section 5 Drugs for Treating Diabetes 2. Oral Hypoglycemic Drugs (1) Sulfonylurea Glipizide
- 1022药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Recombinant Human Interleukin-2
- 1025药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Rituximab
- 药品检验补充检验方法和检验项目批准件编号2006004 Traditional Chinese Medicine for Obesity
- 701药典 化学药和生物制品卷-2010 Chapter IX Drugs for the Endocrine System Section V Drugs for Treating Diabetes II. Oral Hypoglycemic Drugs (1) Sulfonylurea Glibenclamide
- 694药典 化学药和生物制品卷-2010 Chapter 9 Endocrine System Medications Section 5 Drugs for Treating Diabetes 1. Insulin and Insulin Analogs (3) Insulin Analogs Insulin Lispro
- 107药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 2. Cerebral Vasodilator Vinpocetine
- 97药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 1. Thrombolysis, Defibrosis, Anticoagulant Lumbrokinase
- 109药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treating Cerebrovascular Diseases 2. Ligustrazine, a Cerebral Vasodilator
- 695药典 化学药和生物制品卷-2010 Chapter 9 Endocrine System Drugs Section 5 Drugs for Treatment of Diabetes 1. Insulin and Insulin Analogues (3) Insulin Analogues Insulin Aspart
- 65药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 3 Anti-Parkinson’s Disease and Other Movement Disorder Drugs 3. Penicillamine Anti-Other Movement Disorder Drug
- 53药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Other Movement Disorder Drugs 2. Anti-Parkinson's Disease Drug Bromocriptine Mesylate
- 58药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Other Movement Disorder Drugs 2. Anti-Parkinson's Disease Drug Rasagiline Mesylate
- 48药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Other Movement Disorder Drugs 2. Anti-Parkinson's Disease Drug Amantadine Hydrochloride
- 104药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 2. Cerebral Vasodilator Flunarizine Hydrochloride
- 102药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 1. Thrombolysis, Fibrinolysis, Anticoagulant Warfarin Sodium
- 51药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Other Movement Disorder Drugs 2. Anti-Parkinson's Disease Drug Procyclidine Hydrochloride
- 59药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Drugs for Other Movement Disorders 2. Anti-Parkinson's Disease Drug Entocapone
- 104药典 三部-2020 Monograph Ⅱ Therapeutic antirabies serum
- 52药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson’s Disease and Drugs for Other Movement Disorders 2. Anti-Parkinson’s Drug Profenamide Hydrochloride
- 105药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treating Cerebrovascular Diseases 2. Pentoxifylline, a Cerebral Vasodilator
- 95药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 1. Thrombolysis, Defibrinolysis, Anticoagulant Drug Defibrase
- NY/T 4304-2023 Technical specification for prevention and control of common parasitic diseases of yak
- 药品检验补充检验方法和检验项目批准件编号2007003 Chinese patent medicine for treating diabetes
- 46药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 3 Drugs for Anti-Parkinson's Disease and Treatment of Other Movement Disorders 1. Introduction
- 64药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson’s Disease and Other Movement Disorder Drugs 3. Baclofen Anti-Other Movement Disorder Drug
- WS/T 10024-2024 Treatment principles and efficacy assessment of Keshan disease
- 106药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 2. Butylphthalide, a Cerebral Vasodilator
- 717药典 化学药和生物制品卷-2010 Chapter IX Endocrine System Drugs Section 5 Drugs for Treating Diabetes 2. Oral Hypoglycemic Drugs (7) Drugs for Diabetic Complications Pancreatic Kinikreinogenase
- 50药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Other Movement Disorder Drugs 2. Anti-Parkinson's Disease Drug Benztropine Mesylate
- 1026药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Cetuximab
- 67药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 3 Drugs for Anti-Parkinson's Disease and Other Movement Disorders 3. Botulinum Toxin Type A for Anti-Motion Disorders
- 108药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 2. Papaverine, a Cerebral Vasodilator
- 100药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Disease 1. Thrombolysis, Fibrosis Reduction, Anticoagulant Nadroparin Calcium
- 1031药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Gefitinib
- 57药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Other Movement Disorder Drugs 2. Anti-Parkinson's Disease Drug Selegiline Hydrochloride
- 63药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson’s Disease and Drugs for Other Movement Disorders 3. Tetrabenazine Anti-Other Movement Disorders Drugs
- 药品检验补充检验方法和检验项目批准件编号2006005 Chinese patent medicine for treating diabetes
- 1033药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Sunitinib
- 1027药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Bevacizumab
- 55药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Other Movement Disorder Drugs 2. Anti-Parkinson's Disease Drug α-Dihydroergocriptine Mesylate
- 1044药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 4 Other Antineoplastic Drugs and Adjuvant Medicine Elemene
- 101药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 1. Thrombolysis, Defibrosis, Anticoagulant Dalteparin Sodium
- 688药典 化学药和生物制品卷-2010 Chapter 9 Endocrine System Medicines Section 5 Drugs for Treating Diabetes 1. Insulin and Insulin Analogs (1) Animal Insulin Insulin
- 1034药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Ubenimex
- 94药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Disease 1. Thrombolysis, Defibrosis, Anticoagulant Urokinase
- 1032药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Erlotinib
- 56药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Drugs for Other Movement Disorders 2. Anti-Parkinson's Drug Pramipexole Hydrochloride
- 1023药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Trastuzumab
- 1030药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Lapatinib
- 62药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 3 Anti-Parkinson’s Disease and Drugs for Other Movement Disorders 3. Pimozide Anti-Other Movement Disorders
- 60药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 3 Anti-Parkinson’s Disease and Drugs for Other Movement Disorders 2. Anti-Parkinson’s Drug Tolcapone
- 61药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Other Movement Disorder Drugs 3. Anti-Other Movement Disorder Drugs Tiapride Hydrochloride
- 96药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Diseases 1. Thrombolysis, Defibrosis, Anticoagulant Batroxobin
- 1028药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Sorafenib
- 66药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 3 Anti-Parkinson’s Disease and Drugs for Other Movement Disorders 3. Drugs for Anti-Other Movement Disorders Dimercaptosuccinic Acid
- 93药典 化学药和生物制品卷-2010 Chapter 1 Drugs for Nervous System Section 6 Drugs for Treatment of Cerebrovascular Disease 1. Thrombolysis, Defibrosis, Anticoagulant Alteplase
- 1029药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Imatinib
- 1041药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Amsacrine
- 54药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Other Movement Disorder Drugs 2. Anti-Parkinson's Disease Drug Pirabedil
- 1024药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Nimotuzumab
- 47药典 化学药和生物制品卷-2010 Chapter 1 Nervous System Drugs Section 3 Anti-Parkinson's Disease and Other Movement Disorder Drugs 2. Anti-Parkinson's Disease Drug Levodopa
Professional Standard - Hygiene
- WS/T 77-1996 Principles of management on Keshan disease
- WS/T 79-2011 Assessment for therapeutic efficacy on Kashin-Beck disease
- WS/T 314-2009 Principles of management and criteria of evaluating curative effects of Keshan disease
- WS/T 79-1996 The judging of treatment effect on Kashin-beck disease
Hebei Provincial Standard of the People's Republic of China
- DB13/T 715-2005 Technical regulations for the prevention and treatment of common stomach diseases in dairy cows
- DB13/T 1375-2011 Technical regulations for the prevention and treatment of common skin infectious diseases of fur animals
Beijing Provincial Standard of the People's Republic of China
- DB11/T 196-2013 Common fish disease control technical operation rules
- DB11/T 157.8-2008 Technical Specifications for Rainbow Trout Breeding Part 8: Diagnosis and Treatment of Common Diseases and Safe Medication
- DB11/T 196-2003 rules of prevention and cure for familiar disease of fish
Anhui Provincial Standard of the People's Republic of China
- DB34/T 2116-2014 Technical regulations on prevention and treatment of chestnut plaster disease
- DB34/T 4425-2023 Guidelines for the construction of therapeutic drug monitoring laboratories in medical institutions
Jilin Provincial Standard of the People's Republic of China
- DB22/T 2585-2016 Traditional Chinese medicine fumigation washing treatment machine
Hubei Provincial Standard of the People's Republic of China
- DB42/T 2083.1-2023 Technical Regulations for Biological Control of Main Pests and Diseases of Traditional Chinese Medicinal Plants Part 1: Coptis Rhizome
- DB42/T 1640-2021 Technical regulations for biological control of main diseases and insect pests of Chinese herbal medicine Atractylodes macrocephala
- DB42/T 2083.2-2024 Chinese Traditional Medicinal Materials and Pharmaceutical Plants - Biological Control Techniques for Main Diseases and Pests - Part 2: Pinxia (Pinellia ternata)
Code of Federal Regulations (CFR)
- CFR 21-316.23-2013 Food and drugs. Part316:Orphan drugs. Section316.23:Timing of requests for orphandrug designation; designation of already approved drugs.
- CFR 21-316.29-2013 Food and drugs. Part316:Orphan drugs. Section316.29:Revocation of orphan-drug designation.
- CFR 21-890.5150-2013 Food and Drugs. Part890:Physical medicine devices. Section890.5150:Powered patient transport.
- CFR 21-316.28-2013 Food and drugs. Part316:Orphan drugs. Section316.28:Publication of orphan-drug designations.
- CFR 21-316.3-2013 Food and drugs. Part316:Orphan drugs. Section316.3:Definitions.
- CFR 21-316.21-2013 Food and drugs. Part316:Orphan drugs. Section316.21:Verification of orphan-drug status.
- CFR 21-316.50-2013 Food and drugs. Part316:Orphan drugs. Section316.50:Guidance documents.
- CFR 21-316.31-2013 Food and drugs. Part316:Orphan drugs. Section316.31:Scope of orphan-drug exclusive approval.
- CFR 21-316.26-2013 Food and drugs. Part316:Orphan drugs. Section316.26:Amendment to orphan-drug designation.
- CFR 21-316.4-2013 Food and drugs. Part316:Orphan drugs. Section316.4:Address for submissions.
- CFR 21-316.25-2013 Food and drugs. Part316:Orphan drugs. Section316.25:Refusal to grant orphan-drug designation.
- CFR 21-316.24-2013 Food and drugs. Part316:Orphan drugs. Section316.24:Deficiency letters and granting orphan-drug designation.
- CFR 21-316.1-2013 Food and drugs. Part316:Orphan drugs. Section316.1:Scope of this part.
- CFR 21-316.22-2013 Food and drugs. Part316:Orphan drugs. Section316.22:Permanent-resident agent for foreign sponsor.
British Standards Institution (BSI)
- BS EN ISO 21549-7:2016 Health informatics. Patient healthcard data. Medication data
- BS EN ISO 21549-7:2007 Health informatics - Patient healthcard data - Medication data
- DD ENV 12538-1998 Medical informatics. Messages for patient referral and discharge
US Federal Contractor Registration (USFCR)
- FCR FED H-08-9 CHAP 202-1980 DRUG DEPENDENCE TREATMENT CLINIC
- FCR FED H-08-5 CHAP 202 TRANSMITTAL NO.163-1985 DRUG DEPENDENCE TREATMENT CLINIC, TRANSMITTAL NO. 163
- FCR FED H-08-5 CHAP 1-G-1976 NURSING UNIT ALCOHOL TREATMENT (DRAFT)
- FCR FED H-08-5 CHAP 1-F TRANSMITTAL NO.38-1977 NURSING UNIT DRUG DEPENDENCE TREATMENT, TRANSMITTAL NO. 38
International Organization for Standardization (ISO)
- ISO 21549-7:2007 Health informatics - Patient healthcard data - Part 7: Medication data
Magyar Szabványügyi Testület
- MNOSZ 6974-1953 Vitamin medicines for treating animals
German Institute for Standardization
- DIN EN ISO 21549-7:2007 Health informatics - Patient healthcard data - Part 7: Medication data (ISO 21549-7:2007); English version EN ISO 21549-7:2007
- DIN EN ISO 21549-7 E:2016-03 Health Informatics Patient Health Card Data Part 7: Medication Treatment Data (Draft)
- DIN EN ISO 21549-7 E:2014-10 Health Informatics Patient Health Card Data Part 7: Medication Treatment Data (Draft)
Gosstandart of Russia
- GOST 33280-2015 Medicine remedies for veterinary use. Vaccine against leptospirosis of animals. Specifications
- GOST R 52682-2006 Medicine remedies for veterinary use. Terms and definitions
- GOST 33459-2015 Medicine remedies for veterinary use. Vaccines against dermatophytosis of animals. General specification
- GOST R 52683-2006 Medicine remedies for veterinary use. Packing, marking, transportation and storage
- GOST R 52684-2006 Medicine remedies for animals. Acceptance rules, methods of sampling
- GOST 33275-2015 Biological medicine remedies for veterinary use. Vaccines fowl pox. Specifications
Austrian Standards
- ONORM K 2202-1999 Medical informatics - Patient refferal
Standards New Zealand
- NZS 8157:2003 Alcohol and Other Drug Treatment Sector Standard
American Water Works Association (AWWA)
- AWWA IMTECH55810 Common Problems, Proven Cures
Korean Agency for Technology and Standards (KATS)
- KS C IEC 60601-2-9-2002(2012) Patient contact dosemeters used in radiotherapy with electrically connected radiation detectors